Our research: Vaccines

AusGEM’s Vaccines program is focused on developing vaccines for bacterial and parasitic diseases of economically important Australian animals, and methanogens in cattle rumen.

Collaborating with the Vaccine and RNA Design Centre (VRDC), AusGEM is contributing to the development of uniquely Australian mRNA vaccines and RNA therapeutic design capabilities for protecting farmed animals.

Each mRNA vaccine design created will have unique IP and commercialisation potential as critical vaccines and therapeutics in healthcare and conditions impacting animals, including bacterial diseases. They offer the potential for fast redesign and manufacture as needed in response to emerging threats, and novel combination vaccines could be targeted to regions with distinct infectious disease profiles. Broad acceptance of animal mRNA vaccines against certain bacteria could potentially impact AMR by decreasing agricultural antibiotic use, supporting AusGEM’s AMR program.

Through funding provided by the UTS Strategic Research Accelerator (SRA), scientists Dr Piklu Roy Chowdhury (nee: Piklu Bhattacharya), Senior Research Associate and Postdoctoral Research Fellow at AIMI; Dr Pauline M.L. Coulon, Postdoctoral Research Fellow at AIMI; and Dr Maria Rezcallah, Research Associate at AIMI will support our Vaccine program through novel antigen discovery.

To be updated in 2025